John Cameron Bell

John Cameron Bell (born July 10, 1953 in Ancaster, Ontario) is a senior cancer researcher at the OHRI.

He also held Postdoctoral positions at the University of Ottawa with Dr. Michael McBurney, and at the National Institute for Medical Research in London, England with Dr. Gordon Foulkes.

[6] Bell is the founder of the Canadian Oncolytic Virus Consortium, the first of its kind in the world, and it aims to expand cancer viral therapy discovery and application at all levels.

[8] In 2011, viral treatments developed by Bell's lab gained international notoriety following a publication in the journal Nature.

The results presented in the article showed that the viruses were selectively targeting cancerous cells in humans following intravenous injection, and limited further tumour growth.